FORLAX

This brand name is authorized in Austria, Estonia, France, Hong Kong SAR China, Lithuania, Netherlands, Poland, Romania, Singapore, South Africa, Tunisia.

Active ingredients

The drug FORLAX contains one active pharmaceutical ingredient (API):

1	Macrogol 4000 UNII 4R4HFI6D95 - POLYETHYLENE GLYCOL 4000
	High molecular weight (4000) macrogols are long linear polymers which retain water molecules by means of hydrogen bonds. When administered by the oral route, they lead to an increase in volume of intestinal fluids.
	Read more about Macrogol

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
FORLAX Powder for solution	MPI, Generic	Health Products Regulatory Authority (ZA)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
A06AD15	Macrogol	A Alimentary tract and metabolism → A06 Laxatives → A06A Laxatives → A06AD Osmotically acting laxatives
Discover more medicines within A06AD15

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
EE	Ravimiamet	1166576, 1166587, 1166598, 1166600, 1166611, 1166622, 1166644, 1491432
FR	Base de données publique des médicaments	69198794, 69298346
HK	Department of Health Drug Office	41686
LT	Valstybinė vaistų kontrolės tarnyba	1017931, 1017932, 1017933, 1017934, 1017935, 1017936, 1017937, 1029029, 1069894
NL	Z-Index G-Standaard	14770954, 14898586
NL	Z-Index G-Standaard, PRK	53473, 72281
PL	Rejestru Produktów Leczniczych	100145161, 100285169, 100308090, 100327442, 100327608, 100397193, 100432305
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W66205001, W66205002, W66205003, W66205004
SG	Health Sciences Authority	12419P
TN	Direction de la Pharmacie et du Médicament	5133031, 5133032
ZA	Health Products Regulatory Authority	45/11.5/1129